Vanhove K - Search Results

1

Glutamine Addiction and Therapeutic Strategies in Lung Cancer.

Vanhove K, Derveaux E, Graulus GJ, Mesotten L, Thomeer M, Noben JP, Guedens W, Adriaensens P. Vanhove K, et al. Int J Mol Sci. 2019 Jan 10;20(2):252. doi: 10.3390/ijms20020252. Int J Mol Sci. 2019. PMID: 30634602 Free PMC article. Review.

2

Metabolomics a novel biomarker in lung cancer.

Stinkens K, Vanhove K, Thomeer M. Stinkens K, et al. Among authors: vanhove k. J Thorac Oncol. 2015 Jun;10(6):e46. doi: 10.1097/JTO.0000000000000502. J Thorac Oncol. 2015. PMID: 26001150 Free article. No abstract available.

3

Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?

Louis E, Adriaensens P, Guedens W, Vanhove K, Vandeurzen K, Darquennes K, Vansteenkiste J, Dooms C, de Jonge E, Thomeer M, Mesotten L. Louis E, et al. Among authors: vanhove k. Ann Oncol. 2016 Jan;27(1):178-84. doi: 10.1093/annonc/mdv499. Epub 2015 Oct 20. Ann Oncol. 2016. PMID: 26487580 Free article.

4

Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma.

Louis E, Adriaensens P, Guedens W, Bigirumurame T, Baeten K, Vanhove K, Vandeurzen K, Darquennes K, Vansteenkiste J, Dooms C, Shkedy Z, Mesotten L, Thomeer M. Louis E, et al. Among authors: vanhove k. J Thorac Oncol. 2016 Apr;11(4):516-23. doi: 10.1016/j.jtho.2016.01.011. Epub 2016 Feb 29. J Thorac Oncol. 2016. PMID: 26949046 Free article.

5

Metabolic phenotyping of human plasma by ¹ H-NMR at high and medium magnetic field strengths: a case study for lung cancer.

Louis E, Cantrelle FX, Mesotten L, Reekmans G, Bervoets L, Vanhove K, Thomeer M, Lippens G, Adriaensens P. Louis E, et al. Among authors: vanhove k. Magn Reson Chem. 2017 Aug;55(8):706-713. doi: 10.1002/mrc.4577. Epub 2017 Feb 27. Magn Reson Chem. 2017. PMID: 28061019

6

The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer.

Vanhove K, Giesen P, Owokotomo OE, Mesotten L, Louis E, Shkedy Z, Thomeer M, Adriaensens P. Vanhove K, et al. BMC Cancer. 2018 Sep 3;18(1):868. doi: 10.1186/s12885-018-4755-1. BMC Cancer. 2018. PMID: 30176828 Free PMC article.

7

Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.

Vanhove K, Mesotten L, Heylen M, Derwael R, Louis E, Adriaensens P, Thomeer M, Boellaard R. Vanhove K, et al. Cancer Treat Res Commun. 2018;15:7-12. doi: 10.1016/j.ctarc.2017.11.005. Epub 2017 Dec 6. Cancer Treat Res Commun. 2018. PMID: 30207286

8

Correlations between the metabolic profile and ¹⁸F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients.

Vanhove K, Thomeer M, Derveaux E, Shkedy Z, Owokotomo OE, Adriaensens P, Mesotten L. Vanhove K, et al. Sci Rep. 2019 Nov 7;9(1):16212. doi: 10.1038/s41598-019-52667-8. Sci Rep. 2019. PMID: 31700108 Free PMC article.

9

The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism.

Vanhove K, Graulus GJ, Mesotten L, Thomeer M, Derveaux E, Noben JP, Guedens W, Adriaensens P. Vanhove K, et al. Front Oncol. 2019 Nov 15;9:1215. doi: 10.3389/fonc.2019.01215. eCollection 2019. Front Oncol. 2019. PMID: 31803611 Free PMC article. Review.

10

Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.

Pfaehler E, Mesotten L, Zhovannik I, Pieplenbosch S, Thomeer M, Vanhove K, Adriaensens P, Boellaard R. Pfaehler E, et al. Among authors: vanhove k. Med Phys. 2021 Mar;48(3):1226-1238. doi: 10.1002/mp.14684. Epub 2021 Feb 6. Med Phys. 2021. PMID: 33368399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page